Exploring genetic polymorphisms among Plasmodium vivax isolates from the Thai-Myanmar borders using circumsporozoite protein (pvcsp) and ookinete surface protein (pvs25) encoding genes (original) (raw)
Atcheson E, Bauza K, Salman AM, Alves E, Blight J, Viveros-Sandoval ME, Janse CJ, Khan SM, Hill AVS, Reyes-Sandoval A (2018) Tailoring a Plasmodium vivax vaccine to enhance efficacy through a combination of a CSP virus-like particle and TRAP viral vectors. Infect Immun 86(9):e00114-00118. https://doi.org/10.1128/IAI.00114-18 ArticlePubMedPubMed Central Google Scholar
Bibi Z, Fatima A, Rani R, Maqbool A, Khan S, Naz S, Waseem S (2021) Genetic characterization of Plasmodium vivax isolates from Pakistan using circumsporozoite protein (pvcsp) and merozoite surface protein-1 (pvmsp-1) genes as genetic markers. Malar J 20(1):112. https://doi.org/10.1186/s12936-021-03654-w ArticleCASPubMedPubMed Central Google Scholar
Chaurio RA, Pacheco MA, Cornejo OE, Durrego E, Stanley CE Jr, Castillo AI, Herrera S, Escalante AA (2016) Evolution of the transmission-blocking vaccine candidates Pvs28 and Pvs25 in Plasmodium vivax: geographic differentiation and evidence of positive selection. PLoS Negl Trop Dis 10(6):e0004786. https://doi.org/10.1371/journal.pntd.0004786 ArticleCASPubMedPubMed Central Google Scholar
Chaves LB, Perce-da-Silva DS, Totino PRR, Riccio EKP, Baptista BO, de Souza ABL, Rodrigues-da-Silva RN, Machado RLD, de Souza RM, Daniel-Ribeiro CT, Banic DM, Pratt-Riccio LR, Lima-Junior JDC (2019) Plasmodium vivax ookinete surface protein (Pvs25) is highly conserved among field isolates from five different regions of the Brazilian Amazon. Infect Genet Evol 73:287–294. https://doi.org/10.1016/j.meegid.2019.05.003 ArticleCASPubMed Google Scholar
Datoo MS, Natama MH, Somé A, Traoré O, Rouamba T, Bellamy D, Yameogo P, Valia D, Tegneri M, Ouedraogo F, Soma R, Sawadogo S, Sorgho F, Derra K, Rouamba E, Orindi B, Ramos Lopez F, Flaxman A, Cappuccini F, Kailath R, Elias S, Mukhopadhyay E, Noe A, Cairns M, Lawrie A, Roberts R, Valéa I, Sorgho H, Williams N, Glenn G, Fries L, Reimer J, Ewer KJ, Shaligram U, Hill AVS, Tinto H (2021) Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet 397:1809–1818. https://doi.org/10.1016/S0140-6736(21)00943-0 ArticleCASPubMedPubMed Central Google Scholar
Feng H, Zheng L, Zhu X, Wang G, Pan Y, Li Y, Yang Y, Lin Y, Cui L, Cao Y (2011) Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province. China Parasit Vectors 4:224. https://doi.org/10.1186/1756-3305-4-224 ArticleCASPubMed Google Scholar
Friedman-Klabanoff DJ, Berry AA, Travassos MA, Cox C, Zhou Y, Mo AX, Nomicos EYH, Deye GA, Pasetti MF, Laurens MB (2021) Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing. Vaccine 39:1195–1200. https://doi.org/10.1016/j.vaccine.2020.12.023 ArticleCASPubMedPubMed Central Google Scholar
Gomes MD, Vieira JL, Cassiano GC, Musset L, Legrand E, Nacher M, Couto VS, Machado RL, Couto AA (2016) Evaluation of cicumsporozoite protein of Plasmodium vivax to estimate its prevalence in Oiapoque, Amapa state, Brazil, bordering French Guiana. Rev Inst Med Trop Sao Paulo 58:72. https://doi.org/10.1590/S1678-9946201658072 ArticlePubMedPubMed Central Google Scholar
Kaur H, Sehgal R, Kumar A, Sehgal A, Bharti PK, Bansal D, Mohapatra PK, Mahanta J, Sultan AA (2019) Exploration of genetic diversity of Plasmodium vivax circumsporozoite protein (Pvcsp) and Plasmodium vivax sexual stage antigen (Pvs25) among North Indian isolates. Malar J 18(1):308. https://doi.org/10.1186/s12936-019-2939-z ArticleCASPubMedPubMed Central Google Scholar
Kim T-S, Kim H-H, Kim J-Y, Kong Y, Na B-K, Lin K, Moon S-U, Kim Y-J, Kwon M-H, Sohn Y, Kim H, Lee H-W (2011) Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar. Malar J 10:228–228. https://doi.org/10.1186/1475-2875-10-228 ArticleCASPubMedPubMed Central Google Scholar
Le HG, Kang JM, Jun H, Lee J, Moe M, Thai TL, Lin K, Myint MK, Yoo WG, Sohn WM, Kim TS, Na BK (2019) Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolates. Acta Trop 198:105104. https://doi.org/10.1016/j.actatropica.2019.105104 ArticleCASPubMed Google Scholar
Livingstone MC, Bitzer AA, Giri A, Luo K, Sankhala RS, Choe M, Zou X, Dennison SM, Li Y, Washington W, Ngauy V, Tomaras GD, Joyce MG, Batchelor AH, Dutta S (2021) In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP). Sci Rep 11:5318. https://doi.org/10.1038/s41598-021-84622-x ArticleCASPubMedPubMed CentralADS Google Scholar
Sattabongkot J, Tsuboi T, Hisaeda H, Tachibana M, Suwanabun N, Rungruang T, Cao YM, Stowers AW, Sirichaisinthop J, Coleman RE, Torii M (2003) Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates. Am J Trop Med Hyg 69(5):536–541 ArticleCASPubMed Google Scholar
Sharifi-Sarasiabi K, Hosseiniteshnizi S, Dehghan F, Madani A (2015) Genetic diversity of Plasmodium Vivax in South of Iran: a cross-sectional study. J Med Life 8(Spec Iss 2):14–18
Sherrard-Smith E, Sala KA, Betancourt M, Upton LM, Angrisano F, Morin MJ, Ghani AC, Churcher TS, Blagborough AM (2018) Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density. Elife 7:e35213. https://doi.org/10.7554/eLife.35213 ArticlePubMedPubMed Central Google Scholar
Shi YP, Alpers MP, Povoa MM, Lal AA (1992) Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria-endemic regions of Papua New Guinea and Brazil. Am J Trop Med Hyg 47(6):844–851. https://doi.org/10.4269/ajtmh.1992.47.844 ArticleCASPubMed Google Scholar
Snounou G, Singh B (2002) Nested PCR analysis of Plasmodium parasites. Methods Mol Med 72:189–203 CASPubMed Google Scholar
Tsuboi T, Kaslow DC, Gozar MM, Tachibana M, Cao YM, Torii M (1998) Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol Med 4(12):772–782 ArticleCASPubMedPubMed Central Google Scholar
Tsuboi T, Kaneko O, Cao YM, Tachibana M, Yoshihiro Y, Nagao T, Kanbara H, Torii M (2004) A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28. Parasitol Int 53(3):211–216. https://doi.org/10.1016/j.parint.2004.01.012 ArticleCASPubMed Google Scholar